Leading player in the production of synthetic DNA used in gene therapy

Touchlight Adeno Asociated Virus manufactures advanced gene therapy solutions by offering its synthetic, linear, double-stranded DNA as the new industry standard for transfection-based adeno-associated virus (AAV) production. A safer, more efficient, scalable and faster way to manufacture AAVs.

CEO
Alfredo Martínez

WEB
TAAV

DIVESTED COMPANY
2018-2019 (Acquired by Asklepios BioPharmaceutical, Inc.)